Maureen BennettOf Counsel at Jones DaySpeaker
Profile
Maureen Bennett represents life sciences and health care clients conducting global clinical trials and research collaborations. For more than 20 years, Maureen has advised life sciences companies, CROs (contract research organizations), academic medical centers, health care systems, patient focused organizations, and digital health companies on the contractual, regulatory, and ethical issues associated with clinical research.
Maureen regularly advises clients on emerging issues in clinical research, such as strategies to meet clinical trial diversity and health equity objectives, the design and implementation of compliant decentralized clinical trials and telemedicine networks, the structuring of patient recruitment programs, and the development of complex outsourcing arrangements between sponsors, CROs, and site management organizations. She has assisted several clients regarding the conduct of global trials for therapeutics and vaccines to address COVID-19.
Maureen also negotiates clinical trial agreements, reviews informed consents, and assists with interactions with and inspections by regulatory agencies, including the U.S. Food & Drug Administration (FDA).
She also represents clients in the assessment and mitigation of regulatory risks and the negotiation of liability allocation arrangements in M&A, licensing, and other commercial transactions.
Maureen formerly served as co-chair of the Boston Bar Association's Health Care Section. She was honorary co-chair for the 8th Annual Boston-Northwest Ireland Golden Bridges Conference 2022 and is a regular speaker at health industry conferences.
Maureen is a member of the national Board of Directors for Lambda Legal and is co-chair of the Jones Day LGBTQ+ affinity group. She is a member of the Boston College Women's Softball Advisory Board.
Agenda Sessions
Challenges Surrounding the Collection of Race and Ethnicity Data for Clinical Research and HR Purposes
, 09:40View Session